Another area that is easy to overlook is the accuracy and availability of 340B pricing in your wholesaler catalogs. A common reason for pricing discrepancies is that the covered entity has not met a specific manufacturer requirement for a limited distribution drug. But the good news is that the issue can be remedied.
If your TPA doesn’t do this for you proactively, make it an area of focus for your 340B program manager. You can identify potential catalog pricing errors by regularly monitoring run rates at each of your pharmacies to watch for anomalies and by reporting on drugs that are not qualifying through your 340B program. Then investigate the reasons why. You may find that it’s due to a missing 340B catalog price.